- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 403/04
Total number of patents in this class: 7449
10-year publication summary
|
488
|
490
|
475
|
497
|
523
|
468
|
425
|
493
|
388
|
358
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5752 |
150 |
| Bristol-myers Squibb Company | 4826 |
121 |
| Novartis AG | 10612 |
110 |
| Boehringer Ingelheim International GmbH | 4636 |
91 |
| Janssen Pharmaceutica N.V. | 3358 |
86 |
| Syngenta Crop Protection AG | 6259 |
77 |
| Bayer AG | 3401 |
77 |
| F. Hoffmann-La Roche AG | 7937 |
76 |
| AstraZeneca AB | 2857 |
76 |
| Takeda Pharmaceutical Company Limited | 2721 |
68 |
| Merck Sharp & Dohme LLC | 3732 |
68 |
| LG Chem, Ltd. | 17706 |
66 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
63 |
| Hoffmann-La Roche Inc. | 3546 |
61 |
| Rohm and Haas Electronic Materials Korea Ltd. | 331 |
59 |
| Genentech, Inc. | 4016 |
56 |
| Vertex Pharmaceuticals Incorporated | 1630 |
52 |
| Araxes Pharma LLC | 92 |
50 |
| Abbvie Inc. | 1817 |
47 |
| Syngenta Participations AG | 1730 |
45 |
| Other owners | 5950 |